Haemoptysis is defined as the expectoration of blood originating from the tracheobronchial tree or pulmonary parenchyma.
(1) It can be classified as massive or non-massive based on the volume lost. Massive haemoptysis has been described as blood loss ranging from 100-600 mL. However, for the purpose of this article, massive haemoptysis is defined as loss of at least 200 mL of blood in 24 hours or 50 mL per episode.
(2,3) Although massive haemoptysis accounts for only 5% of haemoptysis cases, it is an alarming symptom with an associated mortality of more than 50%. (4) 
HOW RELEVANT IS THIS TO MY PRACTICE?
Haemoptysis is a common presentation in the primary, secondary and tertiary care setting. (5) Hence, it is essential for primary care physicians to be well-versed in the evaluation and management of patients with haemoptysis. This article aimed to discuss the more common differential diagnosis, indications for referral to the emergency department or specialty clinics, and a general management plan for patients with non-massive haemoptysis.
WHAT CAN I DO IN MY PRACTICE?
In the primary care setting, it is important to differentiate between pseudohaemoptysis and haemoptysis. Thereafter, the patient's clinical status needs to be assessed, as well as the quantity of blood lost. The physician should then attempt to identify the cause of the bleeding and determine if a specialist or inpatient referral is needed.
True haemoptysis versus pseudohaemoptysis
When evaluating a patient presenting with expectoration of blood, one must determine the source of the bleeding and determine whether the patient is presenting with true haemoptysis or pseudohaemoptysis. Aetiologies of pseudohaemoptysis include the upper gastrointestinal tract and upper respiratory tract (Table I) . (6, 7) 
Differential diagnosis for haemoptysis
There are multiple causes of haemoptysis. This article focuses on the more common causes such as (a) infective; (b) neoplastic; (c) vascular; (d) autoimmune; and (e) drug-related. A more detailed differential list can be found in Table II . It is also important to assess for any respiratory comorbidities while evaluating patients with haemoptysis.
Infective causes
Pneumonia is a common cause of haemoptysis; in such patients, physicians must look for symptoms and signs of infection such as fever, chest pain and productive cough. It is also important to obtain any relevant contact and/or travel history. Tuberculosis is a common cause of massive haemoptysis, with an incidence rate of 38 per 100,000 population in 2015. (8) It is hence prudent for a practitioner to look for risk factors of tuberculosis. This includes immunosuppression, which may be secondary to immunosuppressive medications or conditions such as human immunodeficiency virus infection or diabetes mellitus.
Neoplastic causes
Neoplastic lesions that can cause haemoptysis can be divided into primary pulmonary lesions and metastatic lesions. If a malignant cause is suspected, physicians should consider a thorough history and examination to look for other primary malignancies such as history of breast, kidney, gastrointestinal, ovarian and cervical cancers. (9) It is important to also elicit constitutional symptoms such as loss of weight and appetite, and to consider the risk factors for primary lung carcinoma such as smoking and occupational exposure.
Vascular causes
Vascular causes of haemoptysis include pulmonary embolism. In patients with suspected pulmonary embolism, the physician should ask if they have a history of recent surgery or immobilisation.
( searching for signs of haemodynamic compromise. The patient's vital signs should be measured and documented. Criteria for admission to the emergency department or referral to specialist clinics are as follows: (6, 15) (a) high risk of massive bleed; (b) gas exchange abnormalities (respiratory rate > 30 breaths/minute, oxygen saturation < 88% room air); (c) haemodynamic instability (e.g. tachycardic, tachypnic, hypotensive patient); (d) other respiratory comorbidities (e.g. previous pneumonectomy, chronic obstructive pulmonary disease); and (e) other comorbidities (e.g. ischaemic heart disease, need for anticoagulants/antiplatelet agents).
Chest radiography is typically recommended for all patients who present with haemoptysis. It is a quick, readily available and cheap modality that can assist in revealing any focal or diffuse parenchymal involvement as well as pleural abnormalities. (4) Other diagnostic modalities include bronchoscopy, multidetector computed tomography (CT), multidetector CT angiography and digital subtraction angiography.
HOW SHOULD I MANAGE HAEMOPTYSIS?
When a patient with non-massive haemoptysis has no haemodynamic instability, a normal chest radiograph and low risk of massive bleeding in the acute setting, no additional testing is required. In a patient with increased risk of malignancy (i.e. 30 pack-years of smoking, age ≥ 40 years), a referral for CT should be considered (Fig. 1) . (6) In a case of massive haemoptysis with haemodynamic instability, the patient's airway, breathing and circulation should be managed first. Patients should be placed in the lateral decubitus position with the affected lung in a dependent position to avoid pooling of blood in the unaffected lung. They should be referred to hospital immediately for further management, including immediate airway control with rigid bronchoscopy or endotracheal intubation, which may be necessary to secure the airway. 
On further questioning, you noted that Mrs

TAKE HOME MESSAGES
1. Haemoptysis is expectoration of blood originating from the tracheobronchial tree.
well. Other signs and symptoms to look out for include dyspnoea, chest pain, tachypnoea and tachycardia.
Autoimmune causes
Vasculitic rash, haematuria, joint pain or swelling may be suggestive of underlying autoimmune diseases such as Wegener's granulomatosis (granulomatosis with polyangiitis), systemic lupus erythematosus (SLE) or Goodpasture syndrome. (12, 13) The characteristic butterfly rash or other skin lesions such as alopecia in SLE may also be found. (14) If autoimmune disease is suspected, the patient should be referred to a specialist centre for further evaluation.
Drug-related causes
Common drugs that may cause haemoptysis include anticoagulants and antiplatelet agents. It is important to elicit further history (i.e. medication history) in order to predict the consequence of stopping medications as part of management.
HOW SHOULD I APPROACH HAEMOPTYSIS?
When approaching a patient with haemoptysis, a proper history has to be taken to narrow down the aetiology of the patient's symptoms. The physician should first exclude the possibility of pseudohaemoptysis and then narrow down the groups of causes for true haemoptysis. It is also paramount to quantify the amount of blood loss and evaluate for any complications due to blood loss. This includes evaluation of signs and symptoms of anaemia and 
Haemoptysis is defined as any blood expelled from the mouth by coughing. 2. Blood from massive nosebleeds that is coughed up through the mouth is the most common and harmless cause of haemoptysis. 3. True haemoptysis is only defined as blood loss from the tracheobronchial tree or pulmonary parenchyma. 4. Multiple episodes of haemoptysis with small amounts of blood that add up to an estimated volume loss of at least 200 mL or more in 24 hours is considered as massive haemoptysis. 5. Massive haemoptysis is rare and accounts for less than 1% of haemoptysis cases. 6. Massive haemoptysis has an associated mortality of above 75%. 7. The five more common causes of haemoptysis can be grouped into infective, neoplastic, vascular, autoimmune and drug-related causes. 8. Pneumonia is not a common underlying cause for patients presenting with haemoptysis. 9. Tuberculosis is a common cause of haemoptysis, but not a common cause of massive haemoptysis. 10. Tuberculosis is a rare diagnosis with an incidence rate of approximately 1-2 per 100,000 population in Singapore and should not be suspected in patients with haemoptysis. 11. Lung metastases that cause haemoptysis can come from other primary malignancies such as breast, kidney, gastrointestinal, ovarian and cervical cancers. 12. The presence of vasculitic rash, haematuria, joint pain or swelling may be suggestive of underlying autoimmune diseases that may contribute to haemoptysis. 13. Common drugs that may increase the risk of haemoptysis include anticoagulants and antiplatelet agents. 14. The presence of haemoptysis caused by anticoagulants and antiplatelet agents is a compelling reason to stop these medications, regardless of their indications. 15. A thorough clinical history-taking and physical examination in the primary care setting is important as it helps to narrow down the differential list and also quantify the amount of blood lost. 16. Chest radiography should be performed for every patient who presents with haemoptysis to screen for any focal or diffuse parenchymal involvement as well as pleural abnormalities. 17. When a patient with non-massive haemoptysis has a normal chest radiograph and no haemodynamic instability, no additional testing is required if the risk of massive bleed is low in the acute setting. 18. A patient presenting with haemoptysis who has a normal chest radiograph but is at increased risk of malignancy (i.e. 30 pack-years of smoking, age ≥ 40 years) will still require computed tomography of the chest. 19. In patients presenting with massive haemoptysis with haemodynamic instability, the priorities of management should be the patient's airway, breathing and circulation. 20. While waiting for the ambulance, the patient should be placed in the lateral decubitus position with the affected lung in a dependent position to avoid pooling of blood in the unaffected lung.
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